U.S. Markets close in 2 hrs 35 mins

Skystar Bio Pharmaceutical Company (SKBI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0001-0.0049 (-98.0000%)
As of 12:58PM EDT. Market open.
People also watch
CPHIBSPMONPZSTNCADC
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201312/31/201212/31/2011
Total Revenue42,483.71633,586.79152,788.279
Cost of Revenue20,992.96215,095.00426,562.748
Gross Profit21,490.75418,491.78726,225.531
Operating Expenses
Research Development956.0282,154.2412,814.328
Selling General and Administrative7,521.8627,786.5658,161.279
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss13,012.8648,550.98115,249.924
Income from Continuing Operations
Total Other Income/Expenses Net531.148594.0721,419.935
Earnings Before Interest and Taxes13,544.0129,145.05316,669.859
Interest Expense612.452764.5140.92
Income Before Tax12,931.568,380.55316,528.939
Income Tax Expense2,401.3082,168.1252,871.299
Minority Interest---
Net Income From Continuing Ops10,530.2526,212.42813,657.64
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income10,530.2526,212.42813,657.64
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares10,530.2526,212.42813,657.64